KPF
TDACW

K2 Principal Fund’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

K2 Principal Fund’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.6K Sell
196,459
-49,230
-20% -$11.3K ﹤0.01% 434
2025
Q4 		$76.2K Sell
245,689
-50,000
-17% -$16.4K 0.01% 337
2025
Q3 		$85.8K Hold
295,689
– – 0.01% 279
2025
Q2 		$68K Hold
295,689
– – 0.01% 244
2025
Q1 		$41.4K Buy
+295,689
New +$52K 0.01% 278

Other funds holding TDACW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

K2 Principal Fund's TDACW Position: Q1 2026 in Review

K2 Principal Fund reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 20% in Q1 2026, selling an estimated $11.3K and leaving 196,459 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

K2 Principal Fund first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $85.8K in Q3 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • K2 Principal Fund held 196,459 shares of Translational Development Acquisition Corp Warrants worth $23.6K as of Q1 2026.
  • K2 Principal Fund sold 49,230 Translational Development Acquisition Corp Warrants shares in Q1 2026, an estimated $11.3K.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of K2 Principal Fund's portfolio in Q1 2026, its #434 holding.
  • K2 Principal Fund first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • K2 Principal Fund's Translational Development Acquisition Corp Warrants position peaked at $85.8K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on K2 Principal Fund's 13F filing for Q1 2026, filed 14 May 2026.